Partnership in Patient Care Holds Planning Retreat

March 12, 2018

Faculty and staff from the UNC Eshelman School of Pharmacy and the UNC Medical Center Department of Pharmacy held a planning retreat for the Partnership in Patient Care at the Friday Center on Feb. 21. Launched in 2010, the Partnership … Continued

Patients Satisfied with Pharmacists Conducting Wellness Visits

February 19, 2018

Patients undergoing a Medicare annual wellness visit say they would be satisfied and comfortable with having a clinical pharmacist practitioner working alone conduct the visit rather than having a physician do it, according to a new study from the University … Continued

Continuing Education for Pharmacists Falls Short on Naloxone

February 16, 2018

Pharmacists who are allowed to dispense naloxone, an opioid reversal agent, without a prescription are often uncomfortable talking to patients about the drug, and the profession’s continuing education programs aren’t helping, according to a new study from the University of … Continued

Time to Get Serious about Nanomaterials Databases, UNC Scientists Say

January 30, 2018

Nanomaterials researchers urgently need well-structured and publicly accessible databases to advance their field, according to scientists at the University of North Carolina at Chapel Hill and the Research Triangle Institute. RTI transferred the Nanomaterial Registry database to UNC-Chapel Hill, and … Continued

Honkakoski Delivers Nuclear Receptor Short Course at UNC

January 22, 2018

Paavo Honkakoski, Ph.D., professor of the School of Pharmacy and Faculty of Health Sciences at the University of Eastern Finland presented a short course on nuclear receptor regulation at the UNC Eshelman School of Pharmacy in January. In two-hour sessions … Continued

UNC Scientists Take a Big Step toward a Better Opioid

January 10, 2018

For the first time, scientists at the University of North Carolina at Chapel Hill and collaborators solved the crystal structure of the activated kappa opioid receptor bound to a morphine derivative. They then created a new drug-like compound that activates only that … Continued